New Research Suggests Physical Activity Reduces Anxiety and Depression in COPD Patients

The benefits of physical activity are widely accepted by scientists and doctors today, with effects observed in weight control, as well as mood and mental health. Now research is showing that increased physical activity among patients with chronic obstructive pulmonary disease (COPD) reduces their risk of anxiety and depression. Results from…

Real-world Study of COPD Patients Shows Nondrug Aerobika Device Reduces Exacerbations

Positive results from a real-world study were recently presented evaluating the effectiveness of the Aerobika Oscillating PEP nondrug device in reducing chronic obstructive pulmonary disease (COPD) exacerbations. Trudell Medical International presented the results of the study at the European Respiratory Society (ERS) International Congress Sept. 3-7 in London. Trudell…

Study of GSK’s COPD Combination Therapy Relvar Ellipta Shows Positive Results

GlaxoSmithKline (GSK) recently presented data showing that its combination drug Relvar Ellipta (fluticasone furoate and vilanterol) causes a statistically significant reduction in the rate of severe lung exacerbations in patients in the Salford Lung Study (SLS), which assessed the safety and effectiveness of the drug in patients with chronic obstructive pulmonary disease (COPD).

Philips Raises Awareness for COPD with Documentary Honoring Star Trek’s Leonard Nimoy

Royal Philips is sponsoring the documentary “COPD: Highly Illogical – Remembering Leonard Nimoy,” a tribute that aims to educate viewers about chronic obstructive pulmonary disease (COPD) through the personal journey of the “Star Trek” star while also providing the latest information about available treatments. The documentary is produced by Nimoy’s daughter, Julie Nimoy, and…